 Detection anti-Epstein-Barr virus trans-activator ZEBRA antibodies sera patients human immunodeficiency virus Patients AIDS AIDS-related complex symptoms Epstein-Barr virus EBV reactivation Several EBV-encoded trans-acting factors EBV lytic cycle ZEBRA BamHI EBV replication activator EBV latent productive cycle Indirect immunofluorescence studies human cells recombinant DNA-harboring cDNA sequence BamHI frame downstream adenovirus major late promoter IgG anti-ZEBRA antibodies high proportion asymptomatic HIV carriers AIDS patients absent healthy control individuals presence anti-ZEBRA antibodies sera HIV-positive patients hypothesis EBV subjects finding practical importance prognostication AIDS development